CD4+CD25+regulatory T cells: II. Origin, disease models and clinical aspects
- 1 October 2004
- Vol. 112 (10) , 642-50
- https://doi.org/10.1111/j.1600-0463.2004.apm1121002.x
Abstract
Autoimmune diseases afflict approximately 5% of the population and reflect a failure in the immune system to discriminate between self and non-self resulting in the breakdown of self-tolerance. Regulatory CD4+CD25+ T cells (Treg cells) have been shown to play an important role in the maintenance of immune homeostasis and self-tolerance by counteracting the development and effector functions of potentially autoreactive T cells. We have in the previous APMIS review described the phenotype and physiology of Treg cells. The present overview deals with the thymic origin of Treg cells and their role in disease models such as autoimmune gastritis and inflammatory bowel disease. Finally, we will consider some aspects of the therapeutic potential of Treg cells.Keywords
This publication has 48 references indexed in Scilit:
- CD4+CD25+ regulatory T cells: I. Phenotype and physiologyAPMIS, 2004
- Positive and Negative Selection of T CellsAnnual Review of Immunology, 2003
- Control of Immune Responses by Naturally Arising CD4+ Regulatory T Cells That Express Toll-like ReceptorsThe Journal of Experimental Medicine, 2003
- Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by LipopolysaccharideThe Journal of Experimental Medicine, 2003
- T Cell Regulation as a Side Effect of Homeostasis and CompetitionThe Journal of Experimental Medicine, 2003
- Regulatory T cells: mediating compromises between host and parasiteNature Immunology, 2003
- Infectious ToleranceThe Journal of Experimental Medicine, 2002
- Two Genetically Separable Steps in the Differentiation of Thymic EpitheliumScience, 1996
- RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangementCell, 1992
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992